Skip to content

High flow oxygen therapy under ultrasound guidance for acute respiratory failure in patients

High flow oxygen therapy under ultrasound guidance for acute respiratory failure in patients

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050823
Enrollment
Unknown
Registered
2021-09-04
Start date
2021-09-10
Completion date
Unknown
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory failure

Interventions

High-flow nasal cannula (HFNC) success group:No
HFNC failure group:No

Sponsors

Changshu First People's Hospital Affiliated to Suzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Meet the following conditions: (1) Respiratory rate > 25 times/min; (2) Under the condition of 10 L/min oxygen inhalation with air bag mask and 15 minutes observation, PaO2/FiO2 of patients was = 7.30; 3. Patients willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe asthma or acute exacerbation of COPD; 2. Patients with severe granulocytopenia ( 10 ug/kg/min, noradrenaline > 0.1 ug/kg/min; 4. Patients with Glasgow Coma Scale score <= 12; 5. Noninvasive ventilation contraindications: weak spontaneous respiration; aspiration; combined with other organ failure; facial trauma; upper abdominal surgery or post-traumatic; deformity; patient uncooperative; 6. Patients who need emergency intubation, refuse intubation and refuse to participate in the experiment; 7. Patients who have been included in this study are readmitted, or are participating in other studies.

Design outcomes

Primary

MeasureTime frame
Ultrasound parameter;Biochemical criterion;Hemodynamic index;Respiratory function;

Countries

China

Contacts

Public ContactXu Chunyang

Changshu First People's Hospital Affiliated to Suzhou University

xuchunsunggg@163.com+86 13913668466

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026